Cerium oxide nanoparticles display antilipogenic effect in rats with non-alcoholic fatty liver disease

Non-alcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease worldwide, ranging from steatosis to non-alcoholic steatohepatitis (NASH). Recently, cerium oxide nanoparticles (CeO(2)NPs) have emerged as a new antioxidant agent with hepatoprotective properties in experime...

Descripción completa

Detalles Bibliográficos
Autores principales: Carvajal, Silvia, Perramón, Meritxell, Oró, Denise, Casals, Eudald, Fernández-Varo, Guillermo, Casals, Gregori, Parra, Marina, González de la Presa, Bernardino, Ribera, Jordi, Pastor, Óscar, Morales-Ruíz, Manuel, Puntes, Víctor, Jiménez, Wladimiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6731222/
https://www.ncbi.nlm.nih.gov/pubmed/31492960
http://dx.doi.org/10.1038/s41598-019-49262-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6731222/
https://www.ncbi.nlm.nih.gov/pubmed/31492960
http://dx.doi.org/10.1038/s41598-019-49262-2

Ejemplares similares